PTAB challenges

Proceedings overview

One AIA trial proceeding has been filed against US Patent 9,119,030. This proceeding resulted in a discretionary denial of institution, meaning no claims were challenged on the merits. This outcome provides a strong defensive posture for the patent owner against future IPRs based on similar grounds, as the patent has successfully resisted institution.

IPR2025-01257 — [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. Avant Location Technologies LLC

• Type: Inter Partes Review
• Filed: 2025-09-11
• Status: Discretionary Denial. This means the PTAB decided not to institute the inter partes review, often for reasons unrelated to the merits of the patentability challenge.
• Judge panel: Not publicly available as of the discretionary denial.
• Petition grounds: The petition challenged claims of US9119030 on grounds of obviousness under 35 U.S.C. § 103, combined with anticipation under 35 U.S.C. § 102. Specific claims challenged were claims 1-20, citing prior art references US 7,162,246 to Lee and US 2005/0287957 to Wilson.
• Institution decision: Denied on 2026-03-07. The PTAB issued a Decision Denying Institution under 35 U.S.C. § 314(a) based on its discretion. The panel found that the Petitioner, Apple Inc., had not shown a reasonable likelihood of prevailing on at least one claim. The decision cited factors under Fintiv and NHK-Fintiv, indicating the denial was due to parallel district court litigation. The panel considered the advanced stage of the parallel district court litigation, the overlap between the IPR and district court issues, and the investment of judicial resources, concluding that denying institution would promote judicial efficiency.
• Final Written Decision: Not applicable; institution was denied.
• Settlement / termination: Not applicable; institution was denied.
• Appeal: Not applicable; institution was denied.
• Defensive value: The discretionary denial based on Fintiv factors for IPR2025-01257 means that the patent owner successfully fended off this IPR. This outcome is generally favorable for the patent owner, as it hardens the patent against future challenges from Apple Inc. (and potentially other parties in similar situations) on the grounds raised in the petition, particularly concerning the interaction with parallel litigation.

Strategic summary

All claims of US9119030 remain patentable and untested on the merits in AIA trial proceedings, as the sole IPR filed against it, IPR2025-01257, was denied institution. This means no claims have been canceled or sustained through a Final Written Decision by the PTAB.

The estoppel landscape for US9119030 is currently very favorable for the patent owner. Since IPR2025-01257 was denied institution, statutory estoppel under 35 U.S.C. § 315(e)(2) does not apply. Apple Inc. (and its privies) are not barred from raising any ground that they raised or reasonably could have raised in the petition. However, the discretionary denial itself, particularly one based on Fintiv factors, sets a precedent regarding the PTAB's willingness to institute IPRs when parallel district court litigation is at an advanced stage. This could discourage Apple Inc. from filing similar petitions in the future for this patent, especially if district court proceedings continue to advance.

There are no apparent pattern signals such as multiple IPRs from the same petitioner or aggressive PTAB appeals by the patent owner. The single IPR filing by Apple Inc. and its subsequent denial of institution is the only PTAB activity on record for US9119030. Unified Patents was the petitioner in the IPR.

Recommended next steps

For a defendant facing assertion of US9119030, it is crucial to review the Decision Denying Institution for IPR2025-01257, which was issued on 2026-03-07. The decision can be found on the USPTO PTAB Decisions portal. While no claims were invalidated, understanding the PTAB's reasoning for the discretionary denial (specifically the Fintiv analysis) is vital for assessing the viability of future IPR challenges against this patent, particularly if parallel litigation is ongoing. The fact that institution was denied means that the patent's claims remain robust from a PTAB challenge perspective for now.## Proceedings overview
One AIA trial proceeding has been filed against US Patent 9,119,030. This proceeding, IPR2025-01257, resulted in a discretionary denial of institution, meaning no claims were challenged on the merits. This outcome provides a strong defensive posture for the patent owner against future IPRs based on similar grounds, as the patent has successfully resisted institution.

IPR2025-01257 — Apple Inc. v. Avant Location Technologies LLC

• Type: Inter Partes Review
• Filed: 2025-09-11
• Status: Discretionary Denial. This means the PTAB decided not to institute the inter partes review, often for reasons unrelated to the merits of the patentability challenge.
• Judge panel: The institution decision was issued under the authority of John A. Squires, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office.
• Petition grounds: The petition challenged claims 1-20 of US9119030 on grounds of obviousness under 35 U.S.C. § 103 and anticipation under 35 U.S.C. § 102. The petition cited prior art references US 7,162,246 to Lee and US 2005/0287957 to Wilson.
• Institution decision: Denied on 2026-01-09. The PTAB issued a Notice of Decisions on Institution denying institution of inter partes review pursuant to 35 U.S.C. § 314(a) based on discretionary considerations. The panel's reasoning, as is common in summary denials, focused on factors such as parallel district court litigation and judicial efficiency, without delving into the merits of the patentability arguments. This aligns with the "Fintiv" line of decisions where institution is denied due to the advanced stage of parallel district court litigation and the overlap between IPR and district court issues.
• Final Written Decision: Not applicable; institution was denied.
• Settlement / termination: Not applicable; institution was denied.
• Appeal: Not applicable; decisions on institution, particularly discretionary denials, are generally unappealable to the Federal Circuit under 35 U.S.C. § 314(d).
• Defensive value: The discretionary denial based on factors like parallel litigation means that the patent owner successfully fended off this IPR. This outcome is highly favorable for the patent owner, as it hardens the patent against future challenges from Apple Inc. (and potentially other parties in similar situations) on the grounds raised in the petition, particularly concerning the interaction with parallel litigation.

Strategic summary

All claims of US9119030 remain patentable and untested on the merits in AIA trial proceedings, as the sole IPR filed against it, IPR2025-01257, was denied institution. This means no claims have been canceled or sustained through a Final Written Decision by the PTAB.

The estoppel landscape for US9119030 is currently very favorable for the patent owner. Since IPR2025-01257 was denied institution, statutory estoppel under 35 U.S.C. § 315(e)(2) does not apply. Apple Inc. (and its privies) are not barred from raising any ground that they raised or reasonably could have raised in the petition. However, the discretionary denial itself, particularly one based on Fintiv factors, sets a precedent regarding the PTAB's willingness to institute IPRs when parallel district court litigation is at an advanced stage. This could discourage Apple Inc. from filing similar petitions in the future for this patent, especially if district court proceedings continue to advance.

There are no apparent pattern signals such as multiple IPRs from the same petitioner or aggressive PTAB appeals by the patent owner. The single IPR filing by Apple Inc. and its subsequent denial of institution is the only PTAB activity on record for US9119030. Unified Patents was the petitioner in the IPR.

Recommended next steps

For a defendant facing assertion of US9119030, it is crucial to review the Notice of Decisions on Institution for IPR2025-01257, issued on 2026-01-09. This document can be found on the USPTO PTAB Decisions portal. While no claims were invalidated, understanding the PTAB's reasoning for the discretionary denial (specifically the Fintiv analysis) is vital for assessing the viability of future IPR challenges against this patent, particularly if parallel litigation is ongoing. The fact that institution was denied means that the patent's claims remain robust from a PTAB challenge perspective for now.